510(k) K020616
K020616 is an FDA 510(k) premarket notification submitted by Bayer Diagnostics Corp. for the device "BAYER RAPIDPOINT 405 SYSTEM". The FDA issued a decision of Substantially Equivalent on July 17, 2002. The device falls under product code GKR (System, Hemoglobin, Automated), a Class II device regulated under 21 CFR 864.5620. Bayer Diagnostics Corp. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- July 17, 2002
- Date Received
- February 25, 2002
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- System, Hemoglobin, Automated
- Device Class
- Class II
- Regulation Number
- 864.5620
- Review Panel
- HE
- Submission Type